FDA Extends Comment Period For Direct-To-Consumer Advertising Guidances
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency has reopened the comment period until Aug. 10 to allow additional time for conducting DTC research, Ad Division Director Tom Abrams says. FDA plans to conduct its own research on the content and format of the brief summary.